Sodium tungstate (Oxolife)
钨酸钠（Oxolife）
Report date: 2022/11/28 22:09:37
Base Information
Drug NameSodium tungstate (Oxolife)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOXOLIFE
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A